Filing Flows

Filing Flows › Labcorp Holdings (LH) › Guidance history

Labcorp Holdings (LH) guidance history: what it guided and what it reported

Labcorp Holdings gave guidance in 13 earnings releases on file since Feb 15, 2024. Of 2 guided periods since reported, it met or beat its own guidance twice (100%). Revenue: 2 of 2, on average +2.7% against the guided midpoint. Its releases raised guidance 5 times and lowered it 0 times.

Revenue

Labcorp Holdings Revenue: last guidance vs reportedLabcorp Holdings Revenue: last guidance vs reportedguided rangereported (above / within / below)Q4 2024Q4 2025$3.5BFY2025$14.0BQ4 2026

Met or beat 2 of 2 periods (1 above, 1 within, 0 below).

PeriodGuided (and how it moved)ReportedResultvs midpoint
Q4 2026$3.5B (Feb 17, 2026)—to be reported—
FY2025$13.9B–$14.1B (Feb 6, 2025)$14.0Bwithin the range-0.1%
Q4 2025$3.3B (Feb 6, 2025)$3.5Babove the range+5.6%
Q4 2024$3.0B (Feb 15, 2024)———

Adjusted revenue

Every guided period is still to be reported.

PeriodGuided (and how it moved)ReportedResultvs midpoint
FY2026$14.6B–$14.8B (Feb 17, 2026)—to be reported—

Adjusted operating income

The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.

PeriodGuided (and how it moved)ReportedResultvs midpoint
FY2026$381M (Apr 30, 2026)—to be reported—
FY2025$326M (Apr 29, 2025)———

Adjusted net income

The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.

PeriodGuided (and how it moved)ReportedResultvs midpoint
FY2025$213M (Apr 29, 2025)———

Free cash flow

The GAAP figure from the filings is shown for each period reported; it is not judged against the guide, which may leave items out (one-off payments, acquisitions).

PeriodGuided (and how it moved)ReportedResultvs midpoint
FY2025$1.1B–$1.2B (Feb 6, 2025)$1.2B (GAAP)not judged—
Q4 2025$665M (Feb 6, 2025)$490M (GAAP)not judged—
FY2024−$1.0B (Apr 25, 2024) → raised $850M–$1.0B (Aug 1, 2024) → lowered $850M–$980M (Oct 24, 2024)$1.1B (GAAP)not judged—

Adjusted EPS

The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.

PeriodGuided (and how it moved)ReportedResultvs midpoint
FY2026$17.55–$18.25 (Feb 17, 2026) → lowered $17.55 (Apr 30, 2026) → raised $18.10–$18.55 (Jul 30, 2026) → raised $18.30–$18.70 (Oct 28, 2026)—to be reported—
Q4 2026$4.07 (Feb 17, 2026)—to be reported—
FY2025$15.60–$16.40 (Feb 6, 2025) → raised $15.70–$16.40 (Apr 29, 2025) → raised $16.05–$16.50 (Jul 24, 2025)———
Q4 2025$3.45 (Feb 6, 2025)———
FY2024$14.30–$15.40 (Feb 15, 2024) → raised $14.45–$15.35 (Apr 25, 2024) → lowered $14.30–$14.90 (Aug 1, 2024) → lowered $14.30–$14.70 (Oct 24, 2024)———
Q4 2024$3.30 (Feb 15, 2024)———

The latest quarter

Labcorp Holdings, Q3 2026: revenue $3.8B (+7% year over year), operating margin 10.6%, net earnings $263M, operating cash flow $564M. The chart follows the revenue to costs, profit and cash.

Questions

Does Labcorp Holdings beat its guidance?

Labcorp Holdings gave guidance in 13 earnings releases on file since Feb 15, 2024. Of 2 guided periods since reported, it met or beat its own guidance twice (100%). Revenue: 2 of 2, on average +2.7% against the guided midpoint.

How often does Labcorp Holdings raise guidance?

Its earnings releases raised guidance 5 times and lowered it 0 times since Feb 15, 2024.

Latest guidance and outlook →

Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.